-
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts
ソース: Buzz FX / 07 10 2024 02:26:10 America/Chicago
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Apellis Pharmaceuticals, Inc.
Read more...